Gold Sponsor
Elekta
At Elekta, we have a united PURPOSE that motivates us as a company and as individuals—Hope for everyone dealing with cancer. It drives us towards our VISION – A world where everyone has access to the best cancer care. And we plan to get there through our MISSION – We improve patient lives by working together with our customers and partners.
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible.
Our offering allows clinicians to treat more patients with increased quality, both with value-creating innovations in solutions and AI-supported service based on a global network.
Varian
Imagine a world free from the fear of cancer. We do, every day. That’s why at Varian, a Siemens Healthineers company, we’re obsessed with creating simpler, more efficient, and more effective technologies to power new victories in cancer care. Varian is the long-standing global leader in comprehensive solutions for radiotherapy and radiosurgery, as well as software systems for planning treatments, managing cancer clinics, sharing knowledge, coordinating care, and using data to deliver evidence-based medicine. To learn more about our solutions, go to http://www.varian.com.
Bronze Sponsor
Contributing Partner
RaySearch Laboratories
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch® markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) that enables cancer clinics to collect, structure and analyze data. RayCommand®, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information: www.raysearchlabs.com.
* Subject to regulatory clearance in some markets.
